EMA/PE/0000225073 - paediatric investigation plan

recombinant parathyroid hormone

Key facts

• Invented name:
  Natpar
• Active substance:
  recombinant parathyroid hormone
• Therapeutic area:
  Endocrine disorders
• Decision number:
  EMA/PE/0000225073
• PIP number:
  EMA/PE/0000225073
• Pharmaceutical form(s):
  Powder and solvent for solution for injection
• Condition(s) / indication(s):
  • Angina pectoris
  • Treatment of hypoparathyroidism
• Route(s) of administration:
  Subcutaneous use
• Decision type:
  W: decision granting a waiver in all age groups for all conditions or indications
• Decision date:
  28/01/2025
• Compliance check done:
  Non

Decision

EMA/PE/0000225073 : EMA decision of 28 January 2025 on the acceptance of a modification of an agreed paediatric investigation plan for recombinant parathyroid hormone (Natpar)

Adopted Reference Number: EMADOC-1700519818-1840304